Herceptin Hylecta Interactions
There are 279 drugs known to interact with Herceptin Hylecta (hyaluronidase/trastuzumab), along with 4 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 55 are major, 142 are moderate, and 82 are minor.
- View all 279 medications that may interact with Herceptin Hylecta
- View Herceptin Hylecta alcohol/food interactions (1)
- View Herceptin Hylecta disease interactions (4)
Most frequently checked interactions
View interaction reports for Herceptin Hylecta (hyaluronidase / trastuzumab) and the medicines listed below.
- Advil Film-Coated (ibuprofen)
- amitriptyline
- amlodipine
- aspirin
- azelastine nasal
- Bisolvon Dry (dextromethorphan)
- buprenorphine
- bupropion
- calcium carbonate
- cephalexin
- Chelated Magnesium (magnesium amino acids chelate)
- colchicine
- dextromethorphan
- Elemental Iron (carbonyl iron)
- Emgality (galcanezumab)
- esomeprazole
- Femara (letrozole)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flonase (fluticasone nasal)
- fluorouracil topical
- folic acid
- haloperidol
- ibuprofen
- indapamide
- irbesartan
- kratom
- l-methylfolate
- meloxicam
- propranolol
- Vitamin B12 (cyanocobalamin)
Herceptin Hylecta alcohol/food interactions
There is 1 alcohol/food interaction with Herceptin Hylecta (hyaluronidase / trastuzumab).
Herceptin Hylecta disease interactions
There are 4 disease interactions with Herceptin Hylecta (hyaluronidase / trastuzumab) which include:
Report options
More about Herceptin Hylecta (hyaluronidase / trastuzumab)
- Herceptin Hylecta consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: HER2 inhibitors
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Arimidex
Arimidex is used to treat breast cancer in postmenopausal women. Learn about side effects ...
Femara
Femara lowers estrogen levels and is used to treat breast cancer in postmenopausal women. Learn ...
Herceptin
Herceptin is used to treat patients with metastatic breast cancer. Learn about side effects ...
Ibrance
Ibrance is used to treat HR-positive, HER2-negative breast cancer in postmenopausal women or men ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.